ABSTRACT: This study was to determine the efficacy of recombinant human bone morphogenetic protien-2 (rhBMP-2)/calcium phosphate matrix (CPX) paste to accelerate healing in a canine articular fracture model with associated subchondral defect. rhBMP-2/CPX (BMP), CPX alone (CPX) or autogenous bone graft (ABG) was administered to a canine articular tibial plateau osteotomy with a subchondral defect in each of 21 female dogs. The unoperated contralateral limbs served as controls. Ground reaction forces, synovial fluid, radiographic changes, mechanical testing, bone density, and histology of bone and synovium were analyzed at 6 weeks after surgery. Radiographic analysis demonstrated that the BMP and CPX groups showed improved bony healing compared to the ABG group at week 6. Histomorphometric analysis demonstrated that the BMP group had significantly increased trabecular bone volume compared to the CPX and ABG groups. Mechanical testing revealed that the BMP group had significantly greater maximum failure loads than the ABG group. Histological analysis demonstrated that the BMP group had significantly less sub-synovial inflammation than CPX group. This study demonstrated that rhBMP-2/CPX accelerated healing of articular fractures with subchondral defect compared to ABG in most of the parameters evaluated, and had less subsynovial inflammation than the CPX alone in a canine model. ß
Articular fractures of the tibial plateau, represent a considerable therapeutic challenge. 1 Injury to the tibial plateau generally occurs from either a direct medial or lateral force, and/or an axial compressive force. The outcome is commonly a sagittal fracture, a depression fracture with metaphyseal bone loss, or a combination of both. 1 Displaced and unstable tibial plateau fractures are considered candidates for surgical stabilization. The principles of surgical management of tibial plateau fractures include anatomic reconstruction of the joint surface, reestablishment of axial alignment, and buttressing of articular segments with autogenous bone graft.
Specific concerns associated with the harvesting of autogenous bone graft (ABG) to aid in fracture repair include: pain at the harvest site postsurgery, nerve damage, arterial injury, and infection rates of up to 10%. 2, 3 This recognized donor site morbidity has driven the development of bone graft substitutes. Several studies have looked at the use of a variety of materials in tibial plateau fractures/defects in both humans and animals. [4] [5] [6] [7] [8] [9] [10] In these studies, calcium phosphate cement (CPC), tricalcium phosphate ceramics, and hydroxyapatite were all considered effective alternatives to autogenous cancellous bone for the filling of metaphyseal defects and buttressing of the articular surface. In vitro biomechanical testing of CPC in tibial plateau fracture models has demonstrated that the cement provides an adequate buttress to the overlying articular surface. 11, 12 CPC is an injectable paste with a crystalline structure similar to bone. CPC sets under endothermic conditions, is biocompatible, biodegradable, and osteoconductive.
However, the ideal bone graft substitute should have not only osteoconductive properties, but also osteoinductive properties to accelerate fracture healing. Bone morphogenetic proteins (BMPs) are soluble, locally acting signaling proteins that belong to the transforming growth factor-beta superfamily. Members of the BMP family are involved in regulating growth, differentiation, and apoptosis of numerous cell types including osteoblasts and chondroblasts. 13, 14 Recombinant human bone morphogenetic protein-2 (rhBMP-2) has been shown to accelerate bone healing in humans and in animal models. [15] [16] [17] [18] [19] rhBMP-2 acts by osteoinduction, signaling of a number of gene expression pathways that are involved in the differentiation of mesenchymal progenitor cells into osteoblasts. [20] [21] [22] [23] [24] [25] rhBMP-2-induced bone undergoes remodeling and integration with surrounding bone by processes that are physiologically equivalent to remodeling of normal host bone. 26 The combination of rhBMP-2/CPC has been shown to accelerate healing in diaphyseal osteotomy animal models. 18, 27 The first objective of this study was to determine the efficacy of rhBMP-2/calcium phosphate matrix (CPX) to accelerate healing in a proximal articular tibial plateau osteotomy model with associated subchondral defect. The second objective of this study was to evaluate the impact of potential joint exposure to rhBMP-2/CPX on joint fluid and associated joint capsular tissue.
MATERIALS AND METHODS

Experimental Design
The study was approved by the Institutional Animal Use and Care Committee. Twenty-one skeletally mature female mixedbreed dogs (mean weight, 25.5 kg; range, 19.5-32.6 kg) were utilized for this study. Following creation of a simulated tibial plateau fracture with subchondral defect in a randomly selected limb, the site was treated with either rhBMP-2/CPX (BMP), CPX alone (CPX), or autongenous bone graft (ABG), and stabilized with a plate. Ground reaction forces, synovial fluid, and radiographic changes were determined at 2, 4, and 6 weeks after surgery. In addition, following euthanasia at 6 weeks, mechanical testing, peripheral quantitative computed tomography (pQCT), and histological analysis were performed on all tibiae. Unoperated, contralateral tibiae served as controls.
rhBMP-2/CPX and CPX Formulations rhBMP-2 was reconstituted with the appropriate volume of pH 4.5 buffer (5.0 mM L-glutamic acid, 5.0 mM NaCl, 2.5% glycine, 0.5% sucose, and 0.01% polysorbate 80). A 0.4 mg/mL rhBMP-2/ CPX paste (BMP) was formulated by adding 0.8 mL of a 0.72 mg/mL rhBMP-2 solution to 1.25 g of CPX powder in the supplied silicone and mixing the resulting paste for 1 min. The CPX paste was formulated by adding 0.8 mL of pH 4.5 buffer to 1.25 g CPX powder and mixing as above. A 1.2 mL volume of paste was generated in both cases.
Surgical Procedure
All animals were premedicated with acepromazine and butorphanol induced with thiopental, and maintained on halothane and oxygen. Cephazolin (22.0 mg/kg, IV) was administered preoperatively and a randomly selected stifle was clipped and aseptically prepared. A 10 cm medial parapatellar incision was made, extending distal to the medial aspect of the tibia. An osteotomy of the tibial plateau was created using an oscillating saw (Model 1370, Stryker Corp., Kalamazoo, MI), from anterior to posterior, just medial to the site of attachment of the anterior cruciate ligament. The osteotomy extended 3 cm distal from the articular surface, exiting out the medial cortex. A 2.7 mm diameter six-hole dynamic compression plate (DCP, Synthesis, Zurich, Switzerland) was then contoured to the medial aspect of the proximal tibia and screw holes were predrilled. A 1-cm diameter spherical void was created in the subchondral bone with a bone curette (Fig. 1) to simulate the compression that occurs clinically. 1 Cancellous bone was removed from both sides of the osteotomy. In the ABG group, the cancellous bone that was removed from the void was replaced, the fragment reduced, and osteotomy was stabilized with the DCP plate using six cortical screws. In the BMP and CPX groups, the BMP or CMP paste was then injected into the subchondral void using a 3.0 cc syringe and 18-gauge spinal needle. One milliliter of BMP or CPX paste was injected directly into the void. The remaining 0.2 ml was placed along the anterior and posterior distal osteotomy lines. Soft tissue closure was routine. Radiographs were taken postoperatively to ensure correct screw placement. Postoperative pain was controlled with butorphanol (0.2 mg/ kg, SQ) and carprofen (2.2 mg/kg, PO, BID).
Radiography
Anterioposterior and mediolateral radiographs were taken of both untreated control and experimental tibiae preoperatively, and of the experimental tibia postoperatively, and at 2, 4, and 6 weeks after surgery. The preoperative radiographs were taken to rule out any preexisting orthopedic disease. The postoperative radiographs were used to determine accuracy of reduction and the maintenance of reduction during healing.
Force Plate Measurements
Weight bearing was measured dynamically with the dogs trotted at a standard velocity (2.5 m/s) over a force platform (ORS6-6-1000; AMTI, Watertown, MA) prior to surgery and at 2, 4, and 6 weeks after surgery as previously described. 27 Mean peak vertical force was determined for each hind limb from three valid foot strikes centered on the platform with the use of commercial software (Acquire, version 6.21W; Sharon Software, DeWitt, MI). The mean peak vertical force was normalized for body weight (N/kg). Foot strikes were considered to be valid when the dog's velocity did not change by more than 10% when approaching the force platform.
Peripheral Quantitative Computed Tomography
Following euthanasia, and removal of plates and screws from the tibial plateau, six transverse images of the proximal tibia were obtained using pQCT (Norland Corp., Fort Atkinson,WI). Starting at the plateau joint surface, the first four images were spaced 0.5 cm apart, covering the region of subchondral bone void. The fifth image was taken 2.5 cm from the joint surface, below the subchondral void but within the level of the osteotomy. The sixth image was taken at 5.0 cm below the joint surface which was 2.0 cm below the distal aspect of the osteotomy in the normal bone (Fig. 1) . Commercially available software (Norland Corp., Fort Atkinson,WI) was used to evaluate the pQCT data for total bone density (TOT), trabecular bone density (TRAB), and cortical-subcortical bone density (Cort-Sub).
Mechanical Testing
Mechanical testing was performed on both operated and contralateral control tibias within 6 h of specimen harvest. Mechanical testing was performed on a modified servohydraulic material testing system (model 858; MTS Systems, Eden Prairie, MN). Axial load was applied over the entire medial fragment at the level of the joint surface. Each tibial plateau was loaded in compression at 450 N/min to apply shear to failure at the osteotomy using load control. Maximum load and deformation was recorded throughout the entire test. Data Figure 1 . Drawing of the canine tibia with the osteotomy line indicated (---) and the region of subchondral bone defect outlined. Bone density was measured at six levels.
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Synovial Fluid Analysis
Synovial fluid was collected via arthrocentesis from all experimental stifles prior to surgery and at 2, 4, and 6 weeks after surgery. Synovial fluid from the contralateral control stifles was also collected at 6 weeks after surgery. Synovial fluid was analyzed for total protein (TP) and total nucleated cell count (TNCC).
Histological Analysis
The methods for processing calcified sections of the canine tibia for histological evaluation have been reported previously. 27 Methylmethacrylate-embedded calcified specimens were sectioned in the coronal plane. Sections were stained with either Goldner's trichrome or Von Kossa stain. A qualitative histological scoring system (0-none, 1-mild, 2-moderate, 3-substantial) was used to evaluate the amount of bone conduction, de novo bone formation, ectopic bone formation, presence of residual CMP or ABG, and perisoteal bone formation. Bone density, defined as an estimate of the percentage of the volume of trabecular bone that occupied the metaphyseal region, was also scored qualitatively (0 ¼ <10%, 1 ¼ 10%-20%, 2 ¼ 20%-40%, 3 ¼ >40%). Synovium was collected from each knee and examined histologically with Safranin-O stain. Both synovial lining hyperplasia and subsynovial inflammation were evaluated with the following numeric scales. For synovial lining hyperplasia: 0 ¼ less than two cell layers with normal cell size; 1 ¼ less than four cell layers with enlarged cell size; 2 ¼ more than four cell layers with enlarged cell size. For subsynovial inflammation: 0 ¼ zero to two lymphocyte nodules, 1 ¼ more than two lymphocyte nodules.
Data Analysis
The mean and standard error of the mean were determined for each quantitative measurement. Median AE 95% confidence intervals were calculated for subjective scores. Repeated measures analysis of variance was used to detect effect of treatments on each dependent variable (peak vertical force, failure load, stiffness) When significance was detected, differences were separated with use of the Duncan multiple-range test. For subjective data, (bone conduction, de novo bone formation, ectopic bone formation, presence of residual CPX or ABG, periosteal bone formation, synovial lining hyperplasia, subsynovial inflammation), the Kruskal-Wallis test was used to separate differences between groups. When differences were detected among groups, the Wilcoxon rank sum test was used to further separate differences among groups. The Fisher's test was used to determine if there were differences in the qualitative appearance of the osteotomy at 6 weeks after surgery between groups. All of the comparisons were twotailed, and significance was always set at p < 0.05. Statistical analysis was performed using a commercially available software program (SAS Release 8e; SAS Institute, Cary, NC).
RESULTS
All animals completed the study. Immediate postoperative radiographs demonstrated adequate reduction of all medial fragments with minimal ( 1 mm) incongruity at the joint surface. Two weeks after surgery, all tibiae showed radiographic signs of at least mild bone resorption at the osteotomy sites. At 6 weeks, significantly fewer osteotomy lines were visible radiographically in the BMP (0 of 7) and CPX (0 of 7) animals compared to the ABG group (5 of 7) (p < 0.05). Adequate reduction of tibial plateau fracture was still maintained in all groups. Peak vertical force decreased on the operated limb after surgery in all of the experimental groups at 2 weeks after surgery. Peak vertical force returned to preoperative levels by week 4 in the ABG animals and by week 6 in the CPX and BMP animals. pQCT demonstrated that the BMP tibiae had significantly greater TRAB (mean AE SEM, 423 AE 14.9 mg/cm 3 ) compared to the CPX tibiae (384 AE 15.7) and ABG tibiae (308 AE 13.1) (p < 0.05). There were no significant differences in TRAB between CPX and ABG (p > 0.05). The values for TOT or Cort-Sub were not significantly different among the experimental groups (p > 0.05). When experimental tibiae were evaluated at individual slice levels, the BMP and CPX tibiae had significantly greater TOT and TRAB than ABG tibiae at slice levels 2, 3, 4 ( Figs. 2 and 3 ). There were no significant differences between BMP and CPX at these levels (p > 0.05). Mechanical testing demonstrated that BMP-treated tibiae had significantly greater maximum failure loads than ABG-treated tibiae (p < 0.05). The difference between the BMP and CPX groups was not significant (p > 0.05). There were no significant differences in stiffness among the three experimental treatment groups (p > 0.05) ( Table 1) . Qualitative evaluation of histologic specimens demonstrated significantly greater bone conduction and periosteal bone formation in the BMP group compared to the other groups (p < 0.05) ( Table 2) . BMP-treated tibiae also showed greater de novo bone formation compared to the CPX-treated tibiae (p < 0.05). CPX group had significantly greater residual carrier than both ABG and BMP groups (p < 0.05). While there was no significant difference in ectopic bone formation or bone density among treatment groups, there was a trend to increase in both parameters in the BMP group (p > 0.05).
TP values in joint fluid significantly increased in each experimental group at 2 and 4 weeks after surgery (p < 0.05). At 6 weeks, the TP in BMP group had returned to preoperative levels, while CPX and ABG groups still maintained a significant increase in TP compared to preoperative levels (Table 3) . No significant changes were seen in TNCC during the course of the experiment in any of the experimental groups (p > 0.05). There was no significant difference in synovial lining hypertrophy among experimental groups (p > 0.05). However, there was a trend (p ¼ 0.08) for the BMP group to have less hypertrophy compared to the CMP and ABG groups. The BMP group (mean AE SEM, 0.0 AE 0.0) revealed significantly less sub-synovial inflammation than the CPX group (mean AE SEM, 0.27 AE 0.12) (p < 0.05). There was also a trend for BMP group to have less inflammation than the ABG group (mean AE SEM, 0.23 AE 0.12) (p ¼ 0.06).
DISCUSSION
This study demonstrated that the application of rhBMP-2/CPX to a canine articular proximal tibial fracture model with associated subchondral defect resulted in better radiographic healing, greater trabecular bone density, better qualitative healing based on histomorphometry, greater maximum failure loads (compared to ABG but not CPX), and less detrimental effects on associated joint capsule tissue than treatment of the osteotomy with either CPX alone or ABG.
In 2003, Keating et al. 4 performed a study to determine depression and split-depression fractures of the tibial plateau treated with calcium phosphate cement, which demonstrated good-to-excellent Rasmussen scores at 6 months in 92% (44/48) of patients and in 95% (42/44) at 1 year in a pilot clinical study. Sellers et al. 28 reported using rhBMP-2 in an absorbable collagen sponge (ACS) to treat full-thickness osteochondral defects in a rabbit model. The use of rhBMP-2/ACS appeared to accelerate trabecular bone formation and filling of the bone defect compared to the conventional ABG technique. Until now, to our knowledge, no studies have been performed to evaluate rhBMP-2 treatment of tibial plateau fractures with subchondral defect.
Force plate results of this study indicated that the BMP and CPX groups returned to normal weight bearing slower than the ABG group. The reason for this earlier return to normal weight bearing at 4 weeks in the ABG group remains unclear. Weight bearing in all of the animals returned to normal values by 6 weeks.
The proximal tibial plateau is primarily composed of trabecular bone. The pQCT results of this study demonstrate that the BMP groups had greater mean trabecular bone density compared to the ABG groups at 6 weeks after surgery, whereas there were no significant differences in the total bone density between the BMP and CPX groups. There were significantly greater levels of CPX residual carrier which artificially elevated the bone density for the CPX group, otherwise the bone density of BMP might be greater than that of CPX.
Mechanical testing of the proximal tibia demonstrated that treatment with rhBMP-2/CPX had significantly greater failure loads compared to treatment with ABG. Kessler et al. 29 demonstrated that treatment with rhBMP-2 delivered in a solvent-dehydrated bone substitute carrier yield strength at least equivalent to physiological cancellous bone at 9 months after implantation in the tibial head of a sheep model. Articular fractures typically induce inflammatory/ hemorrhagic synovitis usually resulting in synovial fluid color changes from transparent to yellow, elevated TNCC, and an increase in TP. An increase in TP concentration was reported at 2 weeks after arthroplasty in rabbits. 30 TP reached maximum values at 4 weeks, and then decreased by 12 weeks back to control levels. For the acute articular tibial plateau osteotomies created in this current study, the TP values were increased in all treatment groups at 2 and 4 weeks after surgery. The TP in rhBMP-2/CPX treatment group returned to preoperative value at 6 weeks after surgery, while the TP in CPX and ABG groups still remained higher than preoperative values.
The synovial hypertrophy is associated with increased numbers of mononuclear cells resembling synoviocytes or macrophages. This current study demonstrated that there was little inflammation and less synovial hypertrophy in the BMP group as reported in a previous study. 31 Future studies will be needed to determine whether synovial development is regulated by BMP signaling.
Several limitations of this study need to be discussed. First, the osteotomy created in this study was similar to a simple medial plateau sagittal fracture with subchondral defect. rhBMP-2 treatment for more complicated tibial plateau compressed fracture may yield different results from this study. Second, the results of this study only apply to acute osteotomies. In addition, the ABG group had only the local bone replaced and there was no iliac or other source as typically done with in the clinical situations. Third, the fracture model created in this study was also to mimic depressed and split tibial plateau fractures occurring clinically. However, no significant differences in maintenance of reduction were detected among groups because of lack of depressed fragments.
In conclusion, treatment of proximal articular tibial plateau osteotomies with associated sub- chondral defect with rhBMP-2/CPX resulted in better bone healing compared to CPX and ABG at 6 weeks after surgery. Less associated synovial inflammation was also observed in the BMP/CPX-treated osteotomies. These results suggest that the combination of rhBMP-2/CPX may be used to accelerate the healing of tibia plateau fractures in people.
